Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Artelo Biosciences, Inc. (ARTL) had Return on Tangible Equity of 93.50% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-3.22M |
|
-- |
|
-- |
|
$3.15M |
|
$-3.15M |
|
$-0.07M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.22M |
|
$-3.15M |
|
$-3.15M |
|
0.57M |
|
0.57M |
|
$-5.61 |
|
$-5.61 |
|
| Balance Sheet Financials | |
$2.23M |
|
-- |
|
$2.12M |
|
$4.36M |
|
$5.71M |
|
-- |
|
$0.05M |
|
$5.76M |
|
$-1.41M |
|
$-3.44M |
|
$-1.41M |
|
0.70M |
|
| Cash Flow Statement Financials | |
$-2.11M |
|
-- |
|
$1.82M |
|
$2.34M |
|
$2.07M |
|
$-0.27M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.39 |
|
-- |
|
-- |
|
-- |
|
-0.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
229.09% |
|
|
Return on Tangible Equity |
93.50% |
-73.93% |
|
229.09% |
|
$-2.00 |
|
$-3.68 |
|
$-3.68 |
|